"BIMO Package" Pilot Designed To Decrease Clinical Trial Inspection Time
This article was originally published in The Gray Sheet
Executive Summary
A pilot program designed by FDA's bioresearch monitoring (BIMO) reengineering team and expected to commence this fall will evaluate whether submission of clinical trial material as a "BIMO package" will help speed up the agency's audits of clinical trial data.